The results from a study in mice demonstrated that Inovio's vaccine generated not only hemagglutination inhibition -based protection against the H7N9 virus but also strong T-cell responses.
http://www.sys-con.com/node/2727043
http://www.sys-con.com/node/2727043
No comments:
Post a Comment